Jing Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jing Zhang has a total of 43 co-authors. Here are the top co-authors by number of shared publications:
Liyan Xi
Department of Dermatology and Venereology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China
3 shared publications- Sha Lu
Department of Dermatology and Venereology, Sun Yat-sen Memorial Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China
3 shared publications Wenying Cai
Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat‐Sen Memorial Hospital Sun Yat‐Sen University Guangzhou China
3 shared publicationsZetao Chen
Department of Dermatology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China
3 shared publications- Huaiqiu Huang
Department of Dermatology and Venereology, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China
2 shared publications Jiahao Li
Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat‐Sen Memorial Hospital Sun Yat‐Sen University Guangzhou China
2 shared publications
Latest Publications
- Open Access
- 12 August 2026
- Published by Springer Nature in BMC Microbiology
- Vol. 26 (1)
Risk factors and antifungal resistance in Candidozyma auris bloodstream infections in Southern China
Background: Candidozyma auris , also known as Candida auris , is an emerging multidrug-resistant fungal pathogen that represents a major global health concern; however, its risk factors and antifungal resistance patterns in bloodstream infections (BSIs) in Southern China remain insufficiently characterized. Therefore, this study aimed to identify risk factors and antifungal resistance patterns associated with C. auris BSIs. Methods: A retrospective analysis was performed on 137 patients with candidemia at a large tertiary hospital in Southern China between October 2023 and September 2025. Least absolute shrinkage and selection operator regression followed by multivariate logistic regression was used to identify independent risk factors, and antifungal susceptibility testing was performed. Minimum inhibitory concentrations were determined and interpreted in accordance with the Clinical and Laboratory Standards Institute M27-A3 guideline. Results: C. auris was identified as the predominant pathogen, accounting for 39.4% (54/137) of candidemia cases, indicating an evident regional predominance and substantial burden. Independent risk factors included hypertension (OR = 6.283, 95% CI: 2.466–17.719), mechanical ventilation (OR = 4.329, 95% CI: 1.585–12.980), use of two or more antibiotics at infection onset (OR = 5.991, 95% CI: 2.349–16.686), and glucocorticoid therapy (OR = 3.100, 95% CI: 1.196–8.509). The 30-day mortality rate associated with C. auris infection was 18.5%. Lower C-reactive protein levels were independently associated with C. auris BSIs (OR = 0.987, 95% CI: 0.978–0.995), potentially reflecting a distinct host inflammatory response rather than representing a predisposing risk factor. Antifungal susceptibility testing revealed universal resistance to fluconazole (100%), while susceptibility to echinocandins was retained. Conclusions: This study identified C. auris as an emerging leading cause of candidemia in this region, characterized by different clinical risk factors and high antifungal resistance, highlighting the importance of early identification and targeted infection control strategies.
- 12 August 2026
- Published by Springer Nature in BMC Microbiology
- Vol. 26 (1)
Open AccessRisk factors and antifungal resistance in Candidozyma auris bloodstream infections in Southern China
Background: Candidozyma auris , also known as Candida auris , is an emerging multidrug-resistant fungal pathogen that represents a major global health concern; however, its risk factors and antifungal resistance patterns in bloodstream infections (BSIs) in Southern China remain insufficiently characterized. Therefore, this study aimed to identify risk factors and antifungal resistance patterns associated with C. auris BSIs. Methods: A retrospective analysis was performed on 137 patients with candidemia at a large tertiary hospital in Southern China between October 2023 and September 2025. Least absolute shrinkage and selection operator regression followed by multivariate logistic regression was used to identify independent risk factors, and antifungal susceptibility testing was performed. Minimum inhibitory concentrations were determined and interpreted in accordance with the Clinical and Laboratory Standards Institute M27-A3 guideline. Results: C. auris was identified as the predominant pathogen, accounting for 39.4% (54/137) of candidemia cases, indicating an evident regional predominance and substantial burden. Independent risk factors included hypertension (OR = 6.283, 95% CI: 2.466–17.719), mechanical ventilation (OR = 4.329, 95% CI: 1.585–12.980), use of two or more antibiotics at infection onset (OR = 5.991, 95% CI: 2.349–16.686), and glucocorticoid therapy (OR = 3.100, 95% CI: 1.196–8.509). The 30-day mortality rate associated with C. auris infection was 18.5%. Lower C-reactive protein levels were independently associated with C. auris BSIs (OR = 0.987, 95% CI: 0.978–0.995), potentially reflecting a distinct host inflammatory response rather than representing a predisposing risk factor. Antifungal susceptibility testing revealed universal resistance to fluconazole (100%), while susceptibility to echinocandins was retained. Conclusions: This study identified C. auris as an emerging leading cause of candidemia in this region, characterized by different clinical risk factors and high antifungal resistance, highlighting the importance of early identification and targeted infection control strategies.
- Open Access
- 24 July 2026
- Published by Elsevier in Photodiagnosis and Photodynamic Therapy
- Vol. 60, 105588
Synergistic effects of photodynamic therapy combined with antifungal agents on fungal infections: A systematic review
- 24 July 2026
- Published by Elsevier in Photodiagnosis and Photodynamic Therapy
- Vol. 60, 105588
Open AccessSynergistic effects of photodynamic therapy combined with antifungal agents on fungal infections: A systematic review
- Open Access
Rapid Detection of Fungi in Nail Specimens Using Multi‐Tube Recombinase Polymerase Amplification Assay
Background: Conventional diagnostic methods for onychomycosis possess disadvantages related to limited sensitivity, extended turnaround times and strong reliance on operator expertise. Objectives: To develop a molecular assay with high sensitivity and specificity for rapid detection of multiple fungal pathogens in nail specimens. Methods: A multi‐tube recombinase polymerase amplification (RPA) assay with fluorescent signal detection was developed, targeting pan‐fungal, Trichophyton rubrum , T. interdigitale , pan‐ Candida , Candida albicans , pan‐ Trichosporon and pan‐ Aspergillus . The analytical sensitivity and specificity of the assay were evaluated using fungal strains, and its performance was assessed in 81 clinical nail specimens in parallel with calcofluor white fluorescence microscopy and fungal culture. Results: The multi‐tube RPA assay demonstrated a detection limit of 1 pg of genomic DNA for all targets, with a turnaround time of < 70 min. In the evaluation of 81 clinical nail specimens, Bayesian latent class analysis estimated sensitivities of 86.0% for multi‐tube RPA, 67.0% for fungal culture and 77.0% for microscopy, with corresponding specificities of 85.0%, 89.0% and 87.0%. The positive and negative predictive values were 92.0% and 72.0% for multi‐tube RPA, 93.0% and 55.0% for fungal culture, and 93.0% and 66.0% for microscopy. Conclusion: Compared with fungal culture and microscopy, the multi‐tube RPA assay demonstrated superior sensitivity while maintaining good specificity, facilitating the identification of fungal pathogens at the species level in nail specimens. Its operational simplicity, enhanced diagnostic performance and reduced processing times make it a promising alternative for the mycological diagnosis of onychomycosis.
Open AccessRapid Detection of Fungi in Nail Specimens Using Multi‐Tube Recombinase Polymerase Amplification Assay
Background: Conventional diagnostic methods for onychomycosis possess disadvantages related to limited sensitivity, extended turnaround times and strong reliance on operator expertise. Objectives: To develop a molecular assay with high sensitivity and specificity for rapid detection of multiple fungal pathogens in nail specimens. Methods: A multi‐tube recombinase polymerase amplification (RPA) assay with fluorescent signal detection was developed, targeting pan‐fungal, Trichophyton rubrum , T. interdigitale , pan‐ Candida , Candida albicans , pan‐ Trichosporon and pan‐ Aspergillus . The analytical sensitivity and specificity of the assay were evaluated using fungal strains, and its performance was assessed in 81 clinical nail specimens in parallel with calcofluor white fluorescence microscopy and fungal culture. Results: The multi‐tube RPA assay demonstrated a detection limit of 1 pg of genomic DNA for all targets, with a turnaround time of < 70 min. In the evaluation of 81 clinical nail specimens, Bayesian latent class analysis estimated sensitivities of 86.0% for multi‐tube RPA, 67.0% for fungal culture and 77.0% for microscopy, with corresponding specificities of 85.0%, 89.0% and 87.0%. The positive and negative predictive values were 92.0% and 72.0% for multi‐tube RPA, 93.0% and 55.0% for fungal culture, and 93.0% and 66.0% for microscopy. Conclusion: Compared with fungal culture and microscopy, the multi‐tube RPA assay demonstrated superior sensitivity while maintaining good specificity, facilitating the identification of fungal pathogens at the species level in nail specimens. Its operational simplicity, enhanced diagnostic performance and reduced processing times make it a promising alternative for the mycological diagnosis of onychomycosis.
- Open Access
- 4 March 2025
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 24 (3) , e70019
A Retrospective Analysis of the Effectiveness of Fractional CO₂ Laser Therapy in Treating Linear Scars: Investigating the Ideal Timing for Intervention
Background: Linear scars, resulting from surgical incisions or traumatic injuries, can pose both aesthetic and functional dilemmas. Ablative fractional CO₂ laser (AFCL) therapy has been recognized for its ability to enhance the appearance and flexibility of scars; however, the ideal timing for such treatments remains a subject of debate.Aims: This study retrospectively evaluates the effectiveness of AFCL in treating linear atrophic and hypertrophic scars, with a focus on identifying the optimal timing to achieve the best possible outcomes.Methods: Patients who underwent treatment for linear scars using AFCL at our hospital between January 2022 and July 2024 were included in the study. Participants were categorized into two groups: those with atrophic scars and those with hypertrophic scars. Hypertrophic scars were assessed using the Vancouver Scar Scale (VSS), whereas atrophic scars were evaluated with the Scar Cosmesis Assessment and Rating (SCAR) scale. Furthermore, considering the timing of scar formation—with a six‐month period as the threshold—two subgroups were categorized as early treatment and late treatment. The disparities in scar improvement rates were then computed and subjected to analysis.Results: Among 55 patients, 31 had atrophic scars and 24 had hypertrophic scars. AFCL treatment significantly improved clinical scores in both groups. The SCAR score for atrophic scars decreased from 6.50 (SD 1.31) to 4.92 (SD 1.71) (p < 0.001), and the VSS score for hypertrophic scars decreased from 6.02 (SD 0.46) to 2.73 (SD 0.39) (p < 0.001). The early‐treatment subgroup showed a 35.38% (SD 24.54%) improvement in atrophic scars, significantly higher than the 12.53% (SD 25.65%) in the late‐treatment subgroup (p = 0.018). No significant timing effect was found for hypertrophic scars (p = 0.764).Conclusion: AFCL is an effective treatment for linear scars. Early intervention, specifically within the first 6 months, leads to superior outcomes for atrophic scars. In contrast, the timing of treatment is less critical for hypertrophic scars.Trial Registration: Chinese clinical trial registry: Registration no. ChiCTR2400092038
- 4 March 2025
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 24 (3) , e70019
Open AccessA Retrospective Analysis of the Effectiveness of Fractional CO₂ Laser Therapy in Treating Linear Scars: Investigating the Ideal Timing for Intervention
Background: Linear scars, resulting from surgical incisions or traumatic injuries, can pose both aesthetic and functional dilemmas. Ablative fractional CO₂ laser (AFCL) therapy has been recognized for its ability to enhance the appearance and flexibility of scars; however, the ideal timing for such treatments remains a subject of debate.Aims: This study retrospectively evaluates the effectiveness of AFCL in treating linear atrophic and hypertrophic scars, with a focus on identifying the optimal timing to achieve the best possible outcomes.Methods: Patients who underwent treatment for linear scars using AFCL at our hospital between January 2022 and July 2024 were included in the study. Participants were categorized into two groups: those with atrophic scars and those with hypertrophic scars. Hypertrophic scars were assessed using the Vancouver Scar Scale (VSS), whereas atrophic scars were evaluated with the Scar Cosmesis Assessment and Rating (SCAR) scale. Furthermore, considering the timing of scar formation—with a six‐month period as the threshold—two subgroups were categorized as early treatment and late treatment. The disparities in scar improvement rates were then computed and subjected to analysis.Results: Among 55 patients, 31 had atrophic scars and 24 had hypertrophic scars. AFCL treatment significantly improved clinical scores in both groups. The SCAR score for atrophic scars decreased from 6.50 (SD 1.31) to 4.92 (SD 1.71) (p < 0.001), and the VSS score for hypertrophic scars decreased from 6.02 (SD 0.46) to 2.73 (SD 0.39) (p < 0.001). The early‐treatment subgroup showed a 35.38% (SD 24.54%) improvement in atrophic scars, significantly higher than the 12.53% (SD 25.65%) in the late‐treatment subgroup (p = 0.018). No significant timing effect was found for hypertrophic scars (p = 0.764).Conclusion: AFCL is an effective treatment for linear scars. Early intervention, specifically within the first 6 months, leads to superior outcomes for atrophic scars. In contrast, the timing of treatment is less critical for hypertrophic scars.Trial Registration: Chinese clinical trial registry: Registration no. ChiCTR2400092038
Prevalence and Antifungal Susceptibility of Sporothrix species in Guangzhou, Southern China
Introduction: Sporotrichosis is a subcutaneous and chronic infection caused by traumatic inoculation of pathogenic sporothrix species, usually infecting the skins and subcutaneous tissues of humans and animals. However, the lack of epidemiological data required further molecular identification to describe the distribution of this fungus in our region. In this study, forty-eight clinical sporothrix isolated from Sun Yat-Sen Memorial Hospital were classified, and the susceptibility of each strain to seven antifungal agents was determined.Methods: Forty strains of S. globosa and eight strains of S. shenkshii were identified via colony morphology and PCR sequencing of calmodulin gene.Results: Antifungal susceptibility tests of the mycelial phase in vitro showed terbinafine (TRB) and luliconazole (LULI) were the most effective, followed by itraconazole (ITZ) and amphotericin B (AMB). By contrast, voriconazole (VCZ), 5-flucytosine (5FC) and fluconazole (FCZ) have low efficacy with high MIC.Conclusion: Our results showed a predominantly S. globosa infection trend in southern China. Simultaneously, sporothrix is sensitive to TRB, LULI, ITZ and AMB whereas resistant to FCZ. This study firstly reports antifungal sensitivity test in vitro and epidemiological correlation analysis of sporothrix in southern China, and also the first time to find that sporothrix is sensitive to LULI.
Prevalence and Antifungal Susceptibility of Sporothrix species in Guangzhou, Southern China
Introduction: Sporotrichosis is a subcutaneous and chronic infection caused by traumatic inoculation of pathogenic sporothrix species, usually infecting the skins and subcutaneous tissues of humans and animals. However, the lack of epidemiological data required further molecular identification to describe the distribution of this fungus in our region. In this study, forty-eight clinical sporothrix isolated from Sun Yat-Sen Memorial Hospital were classified, and the susceptibility of each strain to seven antifungal agents was determined.Methods: Forty strains of S. globosa and eight strains of S. shenkshii were identified via colony morphology and PCR sequencing of calmodulin gene.Results: Antifungal susceptibility tests of the mycelial phase in vitro showed terbinafine (TRB) and luliconazole (LULI) were the most effective, followed by itraconazole (ITZ) and amphotericin B (AMB). By contrast, voriconazole (VCZ), 5-flucytosine (5FC) and fluconazole (FCZ) have low efficacy with high MIC.Conclusion: Our results showed a predominantly S. globosa infection trend in southern China. Simultaneously, sporothrix is sensitive to TRB, LULI, ITZ and AMB whereas resistant to FCZ. This study firstly reports antifungal sensitivity test in vitro and epidemiological correlation analysis of sporothrix in southern China, and also the first time to find that sporothrix is sensitive to LULI.
- 25 April 2023
- Published by Springer Nature in Mycopathologia
- Vol. 188 (5) , 507-514
Epidemiology and Clinical Findings of Tinea Capitis: A 23-Year Retrospective, Single-Center Study in Guangzhou, China
Background Tinea capitis (TC) is one of the most common public health concerns due to its high incidence in preadolescent children. The epidemiological and clinical characteristics of TC vary depending on geographical regions and have changed over the past decades. Objectives This study aimed to identify epidemiological changes in recent decades, including the prevalence and clinical and mycological characteristics of TC in southern China. Methods We conducted a retrospective study at the Department of Dermatology of Sun Yat-sen Memorial Hospital, Sun Yat-sen University from June 1997 to August 2020. Results We retrospectively evaluated 401 TC patients. Of these, 157 patients (39.2%) were preschool children aged 3–7 years and the majority were males. However, the prevalence in children under 3 years old is on the rise (from 19.67% during 1997–2010 to 32.49% during 2011–2020). Grey patches were the most common clinical pattern and mostly occurred in children (71.3%), while the proportion of grey patches and black dots was almost the same in adults. Although Microsporum canis (76%) was the most common causative organism, the number of the T. mentagrophytes complex, as a zoophilic fungus, has increased more than that of the anthropophilic fungi T. violaceum in the recent decade. There was a significant difference in the portion of sex among different age groups, and the gender difference was more notable in the adult group, which showed that the TC prevalence in females was 9 times that in males. In males, M. canis and the T. mentagrophytes complex were the two most common causative fungi, while M. canis and T. violaceum were the two most common causative fungi in females. Additionally, approximately 61.7% of black dot TCs occurred in females. For treatment, oral antifungal therapeutics were widely used in most patients with different treatment durations, although without a significant difference in efficacy (P = 0.106). Conclusions In the last decade, the prevalence of TC in children under 3 years old increased, and boys dramatically outnumbered girls. In adults, the TC prevalence in females is nine times that in males, and most TCs occurring in females are presented as black dots. Moreover, the zoophilic T. mentagrophytes complex has replaced T. violaceum and is now the second most prevalent organism, followed by M. canis of TC.
- 25 April 2023
- Published by Springer Nature in Mycopathologia
- Vol. 188 (5) , 507-514
Epidemiology and Clinical Findings of Tinea Capitis: A 23-Year Retrospective, Single-Center Study in Guangzhou, China
Background Tinea capitis (TC) is one of the most common public health concerns due to its high incidence in preadolescent children. The epidemiological and clinical characteristics of TC vary depending on geographical regions and have changed over the past decades. Objectives This study aimed to identify epidemiological changes in recent decades, including the prevalence and clinical and mycological characteristics of TC in southern China. Methods We conducted a retrospective study at the Department of Dermatology of Sun Yat-sen Memorial Hospital, Sun Yat-sen University from June 1997 to August 2020. Results We retrospectively evaluated 401 TC patients. Of these, 157 patients (39.2%) were preschool children aged 3–7 years and the majority were males. However, the prevalence in children under 3 years old is on the rise (from 19.67% during 1997–2010 to 32.49% during 2011–2020). Grey patches were the most common clinical pattern and mostly occurred in children (71.3%), while the proportion of grey patches and black dots was almost the same in adults. Although Microsporum canis (76%) was the most common causative organism, the number of the T. mentagrophytes complex, as a zoophilic fungus, has increased more than that of the anthropophilic fungi T. violaceum in the recent decade. There was a significant difference in the portion of sex among different age groups, and the gender difference was more notable in the adult group, which showed that the TC prevalence in females was 9 times that in males. In males, M. canis and the T. mentagrophytes complex were the two most common causative fungi, while M. canis and T. violaceum were the two most common causative fungi in females. Additionally, approximately 61.7% of black dot TCs occurred in females. For treatment, oral antifungal therapeutics were widely used in most patients with different treatment durations, although without a significant difference in efficacy (P = 0.106). Conclusions In the last decade, the prevalence of TC in children under 3 years old increased, and boys dramatically outnumbered girls. In adults, the TC prevalence in females is nine times that in males, and most TCs occurring in females are presented as black dots. Moreover, the zoophilic T. mentagrophytes complex has replaced T. violaceum and is now the second most prevalent organism, followed by M. canis of TC.
Deep learning‐based diagnosis models for onychomycosis in dermoscopy
Background: Onychomycosis is a common disease. Emerging noninvasive, real‐time techniques such as dermoscopy and deep convolutional neural networks have been proposed for the diagnosis of onychomycosis. However, deep learning application in dermoscopic images has not been reported.Objectives: To explore the establishment of deep learning‐based diagnostic models for onychomycosis in dermoscopy to improve the diagnostic efficiency and accuracy.Methods: We evaluated the dermoscopic patterns of onychomycosis diagnosed at Sun Yat‐sen Memorial Hospital, Guangzhou, China, from May 2019 to February 2021 and included nail psoriasis and traumatic onychodystrophy as control groups. Based on the dermoscopic images and the characteristic dermoscopic patterns of onychomycosis, we gain the faster region‐based convolutional neural networks to distinguish between nail disorder and normal nail, onychomycosis and non‐mycological nail disorder (nail psoriasis and traumatic onychodystrophy). The diagnostic performance is compared between deep learning‐based diagnosis models and dermatologists.Results: All of 1,155 dermoscopic images were collected, including onychomycosis (603 images), nail psoriasis (221 images), traumatic onychodystrophy (104 images) and normal cases (227 images). Statistical analyses revealed subungual keratosis, distal irregular termination, longitudinal striae, jagged edge, and marble‐like turbid area, and cone‐shaped keratosis were of high specificity (>82%) for onychomycosis diagnosis. The deep learning‐based diagnosis models (ensemble model) showed test accuracy /specificity/ sensitivity /Youden index of (95.7%/98.8%/82.1%/0.809) and (87.5%/93.0%/78.5%/0.715) for nail disorder and onychomycosis. The diagnostic performance for onychomycosis using ensemble model was superior to 54 dermatologists.Conclusions: Our study demonstrated that onychomycosis had distinctive dermoscopic patterns, compared with nail psoriasis and traumatic onychodystrophy. The deep learning‐based diagnosis models showed a diagnostic accuracy of onychomycosis, superior to dermatologists.
Deep learning‐based diagnosis models for onychomycosis in dermoscopy
Background: Onychomycosis is a common disease. Emerging noninvasive, real‐time techniques such as dermoscopy and deep convolutional neural networks have been proposed for the diagnosis of onychomycosis. However, deep learning application in dermoscopic images has not been reported.Objectives: To explore the establishment of deep learning‐based diagnostic models for onychomycosis in dermoscopy to improve the diagnostic efficiency and accuracy.Methods: We evaluated the dermoscopic patterns of onychomycosis diagnosed at Sun Yat‐sen Memorial Hospital, Guangzhou, China, from May 2019 to February 2021 and included nail psoriasis and traumatic onychodystrophy as control groups. Based on the dermoscopic images and the characteristic dermoscopic patterns of onychomycosis, we gain the faster region‐based convolutional neural networks to distinguish between nail disorder and normal nail, onychomycosis and non‐mycological nail disorder (nail psoriasis and traumatic onychodystrophy). The diagnostic performance is compared between deep learning‐based diagnosis models and dermatologists.Results: All of 1,155 dermoscopic images were collected, including onychomycosis (603 images), nail psoriasis (221 images), traumatic onychodystrophy (104 images) and normal cases (227 images). Statistical analyses revealed subungual keratosis, distal irregular termination, longitudinal striae, jagged edge, and marble‐like turbid area, and cone‐shaped keratosis were of high specificity (>82%) for onychomycosis diagnosis. The deep learning‐based diagnosis models (ensemble model) showed test accuracy /specificity/ sensitivity /Youden index of (95.7%/98.8%/82.1%/0.809) and (87.5%/93.0%/78.5%/0.715) for nail disorder and onychomycosis. The diagnostic performance for onychomycosis using ensemble model was superior to 54 dermatologists.Conclusions: Our study demonstrated that onychomycosis had distinctive dermoscopic patterns, compared with nail psoriasis and traumatic onychodystrophy. The deep learning‐based diagnosis models showed a diagnostic accuracy of onychomycosis, superior to dermatologists.
- Open Access
- 16 October 2021
- Published by Springer Nature in Molecular Cancer
- Vol. 20 (1) , 1-7
Correction to: Transcriptional inhibition by CDK7/9 inhibitor SNS-032 abrogates oncogene addiction and reduces liver metastasis in uveal melanoma
- 16 October 2021
- Published by Springer Nature in Molecular Cancer
- Vol. 20 (1) , 1-7
Open AccessCorrection to: Transcriptional inhibition by CDK7/9 inhibitor SNS-032 abrogates oncogene addiction and reduces liver metastasis in uveal melanoma
- 12 June 2019
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 19 (2) , 368-374
Photodynamic therapy for severe facial acne vulgaris with 5% 5‐aminolevulinic acid vs 10% 5‐aminolevulinic acid: A split‐face randomized controlled study
Background: Photodynamic therapy (PDT) with 5‐aminolevulinic acid (ALA) has been described as an effective treatment for severe acne. However, very little evidence exists on the optimal concentration of ALA used in PDT for severe acne.Objectives: To compare the efficacy and safety of PDT with 5% ALA vs 10% ALA in severe acne.Methods: Twenty‐three patients with severe facial acne were randomly assigned to receive PDT with 5% ALA or 10% ALA on the left or right side of the face. Four PDT sessions were conducted with a light dose of 96 J/cm2. The reduction rates of lesion counts between the two groups were compared at the week‐4 and week‐12 follow‐up visits. Effective rate at the week‐12 visit was the primary clinical outcome. Pain and other side effects were evaluated at each visit.Results: The decrease in inflammatory lesions in the 10% ALA group was greater than that in the 5% ALA group at both week‐4 (79.2% vs 62.5%, P = 0.009) and week‐12 follow‐up visits (88.5% vs 78.3%, P = 0.018), while the decrease in noninflammatory lesion counts between the two groups was not statistically significant at each follow‐up visit. The effective rate in the 10% ALA group was significantly higher than that in the 5% ALA group (95.7% vs 69.6%, P = 0.02). No significant difference was observed in pain scores between the two groups except in the first treatment session.Conclusions: Photodynamic therapy using 10% ALA was more effective for severe acne than PDT using 5% ALA.
- 12 June 2019
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 19 (2) , 368-374
Photodynamic therapy for severe facial acne vulgaris with 5% 5‐aminolevulinic acid vs 10% 5‐aminolevulinic acid: A split‐face randomized controlled study
Background: Photodynamic therapy (PDT) with 5‐aminolevulinic acid (ALA) has been described as an effective treatment for severe acne. However, very little evidence exists on the optimal concentration of ALA used in PDT for severe acne.Objectives: To compare the efficacy and safety of PDT with 5% ALA vs 10% ALA in severe acne.Methods: Twenty‐three patients with severe facial acne were randomly assigned to receive PDT with 5% ALA or 10% ALA on the left or right side of the face. Four PDT sessions were conducted with a light dose of 96 J/cm2. The reduction rates of lesion counts between the two groups were compared at the week‐4 and week‐12 follow‐up visits. Effective rate at the week‐12 visit was the primary clinical outcome. Pain and other side effects were evaluated at each visit.Results: The decrease in inflammatory lesions in the 10% ALA group was greater than that in the 5% ALA group at both week‐4 (79.2% vs 62.5%, P = 0.009) and week‐12 follow‐up visits (88.5% vs 78.3%, P = 0.018), while the decrease in noninflammatory lesion counts between the two groups was not statistically significant at each follow‐up visit. The effective rate in the 10% ALA group was significantly higher than that in the 5% ALA group (95.7% vs 69.6%, P = 0.02). No significant difference was observed in pain scores between the two groups except in the first treatment session.Conclusions: Photodynamic therapy using 10% ALA was more effective for severe acne than PDT using 5% ALA.